Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AbbVie announces USD 195 million investment to expand API manufacturing in US

AbbVie seeks USFDA accelerated approval for telisotuzumab vedotin for previously treated non small cell lung cancer

Ruchika Sharma29 Sept 2024 1:15 PM IST

North Chicago: AbbVie has announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for...

Sanofi Rilzabrutinib earns orphan designation in EU for IgG4 related disease

Sanofi, Regeneron get USFDA nod for Dupixent for COPD

Ruchika Sharma29 Sept 2024 12:30 PM IST

Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment...

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults

Ruchika Sharma29 Sept 2024 10:00 AM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY (xanomeline and trospium...

Lupin rolls out constipation drug Prucalopride in US after USFDA nod

Upcoming 50 pharma manufacturing plants under PLI scheme to be completed in 2 years: Centre

Ruchika Sharma28 Sept 2024 4:52 PM IST

New Delhi: The Centre has informed that the 50 upcoming pharmaceutical manufacturing plants under the production-linked incentive (PLI) scheme...

Alembic Pharma appoints Jigr Shah as Head - Business Finance

Alembic Pharma receives USFDA EIR for Oral solid formulation facility (F-1) at Panelav

Ruchika Sharma28 Sept 2024 4:37 PM IST

Vadodara: Alembic Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the...

Jubilant Pharmova to sell API business to wholly owned arm

Drugs in CDSCO samples Counterfeit, not ours, say leading pharma companies

Ruchika Sharma28 Sept 2024 3:33 PM IST

New Delhi: After a series of media articles announcing the results of the Monthly CDSCO drug alert report and pointing how major pharma samples...

Granules India arm gets 1 USFDA observation for Hyderabad facility

USFDA issues three observations each on API, Finished Product side of Lupin Pithampur facility

Ruchika Sharma28 Sept 2024 12:15 PM IST

Mumbai: Lupin has announced that the United States Food and Drug Administration (USFDA) has issued three observations each on the API and...

Shilpa Medicare arm, PPI to form new JV company in Saudi Arabia

Lupin arm ink pact with Celnova for distribution of Orphan Drug NaMuscla in Argentina, Colombia

Ruchika Sharma28 Sept 2024 11:10 AM IST

Mumbai: Global pharma major, Lupin Limited has announced that its subsidiary Lupin Atlantis Holdings SA has entered into a distribution agreement...

Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug Macitentan

Alembic Pharma receives USFDA approval for schizophrenia drug Paliperidone Extended Release

Ruchika Sharma27 Sept 2024 4:40 PM IST

Mumbai: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA)...

Sun Pharma presents new clinical efficacy, safety data in severe dermatological conditions at 2024 EADV Congress

Ruchika Sharma27 Sept 2024 3:51 PM IST

Mumbai: Sun Pharmaceutical Industries Limited has announced that it will present abstracts across its dermatology portfolio at the 33rd European...

Wockhardt group Founder Chairman Dr Habil Khorakiwala bags Lifetime Achievement Award at 10th IHW summit in Dubai

Ruchika Sharma27 Sept 2024 1:04 PM IST

Mumbai: Founder Chairman of Wockhardt group, Dr Habil Khorakiwala was presented the Lifetime Achievement Award at the 10th Integrated Health...

OPPI appoints Bhushan Akshikar as President

Ruchika Sharma27 Sept 2024 12:25 PM IST

Mumbai: The Organisation of Pharmaceutical Producers of India (OPPI), which represents the global research-based pharmaceutical companies in...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok